Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Anglo American restructures exec team as it simplifies portfolio

(Sharecast News) - Anglo American announced the restructure of its executive leadership team on Wednesday, to align with its ongoing portfolio simplification, following the completed demerger of Valterra Platinum and agreed sales of its steelmaking coal and nickel operations. From 1 July, all production businesses would be consolidated under a newly-created chief operating officer role, to be held by Ruben Fernandes.

Themba Mkhwanazi, regional director for Africa and Australia, would step down at the end of June after more than a decade at the company, having played a key role in the demerger of the platinum unit and previously leading its thermal coal, Kumba Iron Ore, and bulks businesses.

Chief executive Duncan Wanblad said the changes marked continued progress in reshaping Anglo American to focus on "world-class positions in copper, premium iron ore and crop nutrients".

The revised leadership structure would include seven functional executives alongside Wanblad and chief financial officer John Heasley.

They included Richard Price, legal and corporate affairs; Monique Carter, people and organisation; Alison Atkinson, projects and development; Helena Nonka, strategy and sustainability; Tom McCulley, technical; Al Cook, CEO of De Beers; and Matt Walker, marketing.

McCulley would also retain responsibility for the crop nutrients business.

De Beers CEO Al Cook would remain on the executive team until the diamond business was further separated from the group.

Meanwhile, the chief executives of Anglo's four production regions - Brazil, Chile, Kumba Iron Ore, and Peru - would report to Fernandes and contribute to group-level decision-making.

At 1214 BST, shares in Anglo American were down 1.54% at 2,084p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.